Bloomberg Businessweek cover image

US, China Agree to Continue Talks on Tariff Truce Extension

Bloomberg Businessweek

00:00

Exploring Synthetic Psilocybin for Depression

This chapter examines the development and clinical promise of synthetic psilocybin as a treatment for treatment-resistant depression affecting millions in the US. It explores the implications of using psilocybin, including sustained symptom relief and the unique setting of its administration. The discussion also addresses challenges in clinical trials and the regulatory landscape for psychedelic therapies, highlighting the need for rigorous study and potential future collaborations.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app